« Heal serious illnesses one day » – Diepresse.com

On the one hand through the willingness to really invest in innovation. At the moment it is 12 billion euros a year worldwide that flow into research – that is around a quarter of our sales.

In Austria it is particularly important to me to expand our portfolio of clinical studies. There are currently 37 studies, significantly more than in other countries. We have been a core country for clinical research within the group since 2023 and are increasingly using synergies with other markets.

This innovation culture is also reflected internally. In addition to personal training programs, we offer a model with our “Grow Assignments” in which team members take on a different role in which they turn to new areas of responsibility and acquire new skills. In addition, J&J stands for international career opportunities, which enables far -reaching experiences and networks – this is also shown by my personal way in the group through various functions and countries worldwide.

Especially, but not only, in cancer therapy, precision medicine is a gamuchanger and therefore one of our most important priorities.

Precision medicine enables cancer patients a therapy tailored to the molecular profile of your tumor, exactly at the right time. Here we do research in the areas of lung and bladder carcinoma. For the multiple myeloma, an innovative therapy portfolio for all disease stages of J&J with different mechanisms of action, including cell therapy, is available in Austria.

Outside of oncology/hematology, we also research in the areas of neuroscience, immunology and cardio pulmology to expand existing therapy concepts. Further research approaches, such as genetic therapies in hereditary eye diseases, are examined. The aim of our research is to recognize heavy diseases that have previously been inadequate, treated at an early stage, treat it individually and heal one day.

We see ourselves as a strong pillar of the health system on several levels. We offer patients in Austria access to innovative medicines and also help the state to reduce the (subsequent) costs of serious illnesses.

We also cooperate closely with experts and organizations in the healthcare system and support patients in everyday life with advice and action – from online collectors to checklists. In order to strengthen the patient’s voice and better integrate their perspectives into the therapy care, we support various patient representatives with a lot of personal commitment.

In addition to clinical research, we invest in basic research, which has a positive effect on the knowledge of illnesses and possible therapy approaches. As part of a public private partnership, we, as a company partner, support the Christian-Doppler-Labor at the Medical University of Vienna at the end of April, which is devoted to basic research by chronic-inflammatory skin diseases.

For me, responsibility primarily means making an active contribution, promoting medical science and sustainably improving health care in Austria. We want to increase the quality of life of people with serious and rare illnesses and heal them one day. I also see it as our task to relieve the health system through innovation and to facilitate care work.

Another central concern for me is to have a positive effect on our communities. For this, for example, we rely on cooperation programs with international NGOs, in which our employees work for the NGO for a certain period of time, virtually, but also in presence. I worked for half a year at the AGA Khan Foundation and University in East Africa and helped strengthen the quality of and the accessibility to health care.

In general, we enable our employees four « Volunteering Days » a year to be able to get socially committed and take part locally with a lot of commitment to charity actions such as J & J Cycling for Children, the cancer research run or Wings for Life World Run.

For me, every innovative therapy that we develop and arrives in patients is a great success – as well as a motivated and satisfied team that pulls together with me and lives our credo.

For me personally, success means to be happy with the decisions that I have made, to see my family and hopefully leave the world in a better condition than I found it.